128 related articles for article (PubMed ID: 6525998)
1. CDP-choline does not inhibit erythrocyte glycolytic or pentose phosphate pathway enzyme activity.
Lachant NA; Tanaka KR
Enzyme; 1984; 32(4):228-31. PubMed ID: 6525998
[TBL] [Abstract][Full Text] [Related]
2. Hemolytic anemia in hereditary pyrimidine 5'-nucleotidase deficiency. II. Effect of pyrimidine nucleotides and their derivatives on glycolytic and pentose phosphate shunt enzyme activity.
Oda E; Oda S; Tomoda A; Lachant NA; Tanaka KR
Clin Chim Acta; 1984 Aug; 141(2-3):93-100. PubMed ID: 6091951
[TBL] [Abstract][Full Text] [Related]
3. Selective accumulation of cytosol CDP-choline as an isolated erythrocyte defect in chronic hemolysis.
Paglia DE; Valentine WN; Nakatani M; Rauth BJ
Proc Natl Acad Sci U S A; 1983 May; 80(10):3081-5. PubMed ID: 6574471
[TBL] [Abstract][Full Text] [Related]
4. Identification of cytidine diphosphodiesters in erythrocytes from a patient with pyrimidine nucleotidase deficiency.
Swanson MS; Markin RS; Stohs SJ; Angle CR
Blood; 1984 Mar; 63(3):665-70. PubMed ID: 6320931
[TBL] [Abstract][Full Text] [Related]
5. Red cell CDP (dCDP)-choline and P-choline in normal subjects and in certain hemolytic syndromes.
Valentine WN; Jenden DJ; Paglia DE
Am J Hematol; 1984 Jul; 17(1):89-92. PubMed ID: 6331156
[TBL] [Abstract][Full Text] [Related]
6. Abnormal erythrocyte pyrimidine nucleotides in uremic subjects.
Angle CR; Swanson MS; Stohs SJ; Markin RS
Nephron; 1985; 39(3):169-74. PubMed ID: 2983249
[TBL] [Abstract][Full Text] [Related]
7. Effect of cytidine(5')diphosphocholine (CDP-choline) on the total urinary excretion of 3-methoxy-4-hydroxyphenylglycol (MHPG) by rats and humans.
Lopez I; Coviella G; Agut J; Wurtman RJ
J Neural Transm; 1986; 66(2):129-34. PubMed ID: 3746287
[TBL] [Abstract][Full Text] [Related]
8. A family with chronic haemolysis and selective accumulation of erythrocyte CDP-choline.
Petersen A; Borregaard N
Leukemia; 1997 Aug; 11(8):1373-6. PubMed ID: 9264395
[TBL] [Abstract][Full Text] [Related]
9. Oxotremorine-induced cholinergic syndrome: modifications by levodopa and/or oral cytidine diphosphocholine.
Saligaut C; Daoust M; Chadelaud M; Moore N; Chretien P; Boismare F
Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):5-8. PubMed ID: 3990445
[TBL] [Abstract][Full Text] [Related]
10. Detection of pyrimidine 5'-nucleotidase deficiency using 1H- or 31P-nuclear magnetic resonance.
Kagimoto T; Shirono K; Higaki T; Oda T; Matsuzaki H; Nagata K; Nakaji T; Morino Y; Takatsuki K
Experientia; 1986 Jan; 42(1):69-72. PubMed ID: 3002842
[TBL] [Abstract][Full Text] [Related]
11. Effects of the phenacetin metabolite 4-nitrosophenetol on glycolysis and pentose phosphate pathway in human red cells.
Gallemann D; Eyer P
Biol Chem Hoppe Seyler; 1993 Jan; 374(1):37-49. PubMed ID: 8439396
[TBL] [Abstract][Full Text] [Related]
12. Cytidine-5'-diphosphocholine affects CTP-phosphocholine cytidylyltransferase and lyso-phosphatidylcholine after transient brain ischemia.
Adibhatla RM; Hatcher JF; Dempsey RJ
J Neurosci Res; 2004 May; 76(3):390-6. PubMed ID: 15079868
[TBL] [Abstract][Full Text] [Related]
13. CDP-choline: pharmacological and clinical review.
Secades JJ; Frontera G
Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
[TBL] [Abstract][Full Text] [Related]
14. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
Lachant NA; Zerez CR; Tanaka KR
Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal administration of CDP-choline or a combination of cytidine plus choline improves nerve regeneration and functional recovery in a rat model of sciatic nerve injury.
Caner B; Kafa MI; Bekar A; Kurt MA; Karli N; Cansev M; Ulus IH
Neurol Res; 2012 Apr; 34(3):238-45. PubMed ID: 22449436
[TBL] [Abstract][Full Text] [Related]
16. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine.
Agut J; Coviella IL; Wurtman RJ
Neuropharmacology; 1984 Dec; 23(12A):1403-6. PubMed ID: 6543245
[TBL] [Abstract][Full Text] [Related]
17. Cytidine-5-diphosphocholine reduces microvascular permeability during experimental endotoxemia.
Schmidt K; Hernekamp JF; Doerr M; Zivkovic AR; Brenner T; Walther A; Weigand MA; Hofer S
BMC Anesthesiol; 2015 Aug; 15():114. PubMed ID: 26232247
[TBL] [Abstract][Full Text] [Related]
18. Study on the protection of CDP-choline against nicotine intoxication.
Grau T; Romero A; Sacristán A; Ortiz JA
Arzneimittelforschung; 1983; 33(7A):1025-6. PubMed ID: 6684456
[TBL] [Abstract][Full Text] [Related]
19. Engineering substrate and energy metabolism for living cell production of cytidine-5'-diphosphocholine.
Ren Y; Liu Q; Liu H; Zhou X; Zhang Y; Cai M
Biotechnol Bioeng; 2020 May; 117(5):1426-1435. PubMed ID: 31997310
[TBL] [Abstract][Full Text] [Related]
20. High-level living cell production of cytidine-5'-diphosphocholine in metabolically engineered yeast.
Ren Y; Liu Q; Liu H; Zhou X; Zhang Y; Cai M
J Biotechnol; 2021 Nov; 341():129-136. PubMed ID: 34536458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
